U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H7NO2
Molecular Weight 149.1467
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ACETIMIDOQUINONE

SMILES

CC(=O)N=C1C=CC(=O)C=C1

InChI

InChIKey=URNSECGXFRDEDC-UHFFFAOYSA-N
InChI=1S/C8H7NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5H,1H3

HIDE SMILES / InChI

Molecular Formula C8H7NO2
Molecular Weight 149.1467
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Zebrafish teratogenicity test with metabolic activation (mDarT): effects of phase I activation of acetaminophen on zebrafish Danio rerio embryos.
2010-09-10
Differential effect of covalent protein modification and glutathione depletion on the transcriptional response of Nrf2 and NF-kappaB.
2010-08-01
c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity.
2010-07
Enzyme immobilized magnetic nanoparticles for in-line capillary electrophoresis and drug biotransformation studies: application to paracetamol.
2010-07
Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans.
2010-07
Genetic analysis of cytoprotective functions supported by graded expression of Keap1.
2010-06
Susceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice.
2010-05-01
The effect of acetaminophen nanoparticles on liver toxicity in a rat model.
2010-04-07
Acetaminophen induced acute liver failure via oxidative stress and JNK activation: protective role of taurine by the suppression of cytochrome P450 2E1.
2010-03
Electrochemical evidences in oxidation of acetaminophen in the presence of glutathione and N-acetylcysteine.
2010-01-21
Mechanism of protection by metallothionein against acetaminophen hepatotoxicity.
2010-01-15
Zinc Supplementation with Polaprezinc Protects Mouse Hepatocytes against Acetaminophen-Induced Toxicity via Induction of Heat Shock Protein 70.
2010-01
Fluorescence-based liver microsomal assay for screening of pharmaceutical reactive metabolites using a glutathione conjugated 96-well plate.
2010-01
Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation.
2010-01
The role of para-aminophenol in acetaminophen-induced methemoglobinemia in dogs and cats.
2009-12
[Dosing time based on molecular mechanism of biological clock of hepatic drug metabolic enzyme].
2009-11
Life-threatening hyponatremia due to intravenous n-acetylcysteine treatment in an infant: a case report.
2009-09-01
Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury.
2009-09
Reduced exposure of imatinib after coadministration with acetaminophen in mice.
2009-08
Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure.
2009-08
Management of the critically poisoned patient.
2009-06-29
The protective effects of garlic extract against acetaminophen-induced oxidative stress and glutathione depletion.
2009-05-15
Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice.
2009-05
Metabolism of acetaminophen (paracetamol) in plants--two independent pathways result in the formation of a glutathione and a glucose conjugate.
2009-03
Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
2009-01-13
Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes.
2009-01
Reduced acetaminophen-induced liver injury in mice by genetic disruption of IL-1 receptor antagonist.
2009-01
Current concepts of mechanisms in drug-induced hepatotoxicity.
2009
Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity.
2009
The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system.
2008-10
Prevention of acetaminophen (APAP)-induced hepatotoxicity by leflunomide via inhibition of APAP biotransformation to N-acetyl-p-benzoquinone imine.
2008-08-28
Interspecies differences in acetaminophen sensitivity of human, rat, and mouse primary hepatocytes.
2008-06
Mitochondrial protein thiol modifications in acetaminophen hepatotoxicity: effect on HMG-CoA synthase.
2008-04-01
Acetaminophen-induced liver damage in mice: effects of some medicinal plants on the oxidative defense system.
2008-03
Glutathione-S-transferase pi as a model protein for the characterisation of chemically reactive metabolites.
2008-01
Automated detection of covalent adducts to human serum albumin by immunoaffinity chromatography, on-line solution phase digestion and liquid chromatography-mass spectrometry.
2007-11-15
Are we getting enough sulfur in our diet?
2007-11-06
Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice.
2007-10
Monitoring paracetamol metabolism after single and repeated administration in pediatric patients with neoplastic diseases.
2007-09
Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study.
2007-08-10
Liquid chromatography/tandem mass spectrometry detection of covalent binding of acetaminophen to human serum albumin.
2007-08
Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice.
2007-07
Protein targets of reactive electrophiles in human liver microsomes.
2007-06
The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study.
2007-05-30
Development and evaluation of an electrochemical method for studying reactive phase-I metabolites: correlation to in vitro drug metabolism.
2007-05
Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.
2007-02-12
Pharmacokinetics/pharmacodynamics of acetaminophen analgesia in Japanese patients with chronic pain.
2007-01
Abstracts of papers presented at the 2007 pittsburgh conference.
2007
Use of a standardised and validated long-term human hepatocyte culture system for repetitive analyses of drugs: repeated administrations of acetaminophen reduces albumin and urea secretion.
2007
Chronoamperometric determination of paracetamol using an avocado tissue (Persea americana) biosensor.
2001-10-31
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:36:56 GMT 2025
Edited
by admin
on Mon Mar 31 19:36:56 GMT 2025
Record UNII
G6S9BN13TI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ACETIMIDOQUINONE [MI]
Preferred Name English
ACETIMIDOQUINONE
MI  
Common Name English
N-ACETYL-P-BENZOQUINONIMINE
Common Name English
NAPQI
Common Name English
ACETAMIDE, N-(4-OXO-2,5-CYCLOHEXADIEN-1-YLIDENE)-
Systematic Name English
N-ACETYL-P-BENZOQUINONE IMINE
Common Name English
N-ACETYL-P-QUINONEIMINE
Common Name English
N-ACETYL-4-BENZOQUINONEIMINE
Systematic Name English
Code System Code Type Description
MERCK INDEX
m1326
Created by admin on Mon Mar 31 19:36:56 GMT 2025 , Edited by admin on Mon Mar 31 19:36:56 GMT 2025
PRIMARY Merck Index
PUBCHEM
39763
Created by admin on Mon Mar 31 19:36:56 GMT 2025 , Edited by admin on Mon Mar 31 19:36:56 GMT 2025
PRIMARY
MESH
C028473
Created by admin on Mon Mar 31 19:36:56 GMT 2025 , Edited by admin on Mon Mar 31 19:36:56 GMT 2025
PRIMARY
CHEBI
29132
Created by admin on Mon Mar 31 19:36:56 GMT 2025 , Edited by admin on Mon Mar 31 19:36:56 GMT 2025
PRIMARY
WIKIPEDIA
NAPQI
Created by admin on Mon Mar 31 19:36:56 GMT 2025 , Edited by admin on Mon Mar 31 19:36:56 GMT 2025
PRIMARY
EPA CompTox
DTXSID20198756
Created by admin on Mon Mar 31 19:36:56 GMT 2025 , Edited by admin on Mon Mar 31 19:36:56 GMT 2025
PRIMARY
FDA UNII
G6S9BN13TI
Created by admin on Mon Mar 31 19:36:56 GMT 2025 , Edited by admin on Mon Mar 31 19:36:56 GMT 2025
PRIMARY
CAS
50700-49-7
Created by admin on Mon Mar 31 19:36:56 GMT 2025 , Edited by admin on Mon Mar 31 19:36:56 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE TOXIC
Metabolite produced hepatic necrosis in man.
AMOUNT EXCRETED
URINE
PARENT -> METABOLITE TOXIC
Metabolite produces hepatic necrosis in man.